HEALTH TECHNOLOGY, DIGITAL HEALTHCARE
Prnewswire | March 30, 2023
Getz Healthcare Pty Ltd announced that they have partnered with Subtle Medical, a U.S-based healthcare technology company, to distribute the company's artificial intelligence (AI)-based software solutions for faster and safer medical imaging. Subtle's solutions could provide significant efficiency gains for hospitals and private radiology clinics within Australia and New Zealand, resulting in more timely patient access to critical PET and MRI imaging services.
Subtle Medical's software solution, SubtlePET™, uses proprietary deep learning algorithms to denoise low count PET images from up to 75% lower radiotracer dose and faster scan times. SubtleMR™ uses increased sharpness and denoising to improve the image quality on up to 60% faster MRI exams. The solutions result in a broad range of benefits including faster scan times, lower radiation dose, improved image quality, higher scanner efficiency, and positive impacts on workflow and patient experience. Subtle's solutions are compatible across all PET and MRI scanner brands, makes, and models, and seamlessly integrate into existing workflows.
"We are thrilled to be expanding patient access to our AI solutions. Our goal is to not only make medical imaging safer and more focused on the patient, but also help imaging institutions and radiologists achieve higher quality imaging while running a more efficient operation. We are looking forward to a productive partnership with Getz," said Josh Gurewitz, Chief Commercial Officer at Subtle Medical.
James Simkins, CEO, Getz Healthcare, added, "We are really excited to be partnering with Subtle Medical. We believe Subtle Medical's software solution will bring tangible benefits to our customers and ultimately patients." "The possibility for Subtle Medical's software solutions to improve efficiency and image quality while extending the life of existing imaging systems is a real game changer for radiologists and patients in need of access to imaging. We are delighted to introduce this technology to Australia and New Zealand," said Kimberly Hill, Managing Director of Getz Healthcare Australia & New Zealand.
About Subtle Medical
Subtle Medical, Inc. is an innovative healthcare technology company with a suite of software solutions that use deep learning to increase the quality and efficiency of medical imaging. It is a CB Insights Top AI 100 and two-time Digital Health 150 company and is an Nvidia Inception Award Winner.
Subtle's (AI) software solutions have been commercially deployed in over 400 sites worldwide. SubtleMR™ and SubtlePET™ use deep learning to improve the image quality of accelerated MRI and PET scans, boosting exam throughput and profitability for centers, and getting patients in and out of the scanner faster. The company continues to expand globally with the support of recent Series B funding, bringing total funding to over $45 million.
About Getz Healthcare
Getz Healthcare is proud to be recognized as the leading distributor of medical equipment, devices and consumables, in Asia Pacific. We are an ISO 9001:2015 certified company, and we partner with leading manufacturers in medical technology, to offer a wide range of innovative and high-quality products & solutions, enabling our customers to focus on what's important – providing better care for their patients.
Headquartered in Singapore, we have been operating in the Asia region for over 110 years, serving over 7,500 customers, from our 23 offices and distribution centers, spread across Australia, Hong Kong, Malaysia, New Zealand, Pakistan, Philippines, Taiwan, Thailand and Vietnam.
HEALTH TECHNOLOGY, DIGITAL HEALTHCARE
Memora Health and Perigen | January 09, 2023
Memora Health, one of the leaders in virtual care delivery and managing complex care, teamed up with PeriGen, a pioneer in using AI to make childbirth safer.
Memora Health, which has the finest intelligent platform for virtual care delivery and managing complex care, announced a partnership with PeriGen, the market leader in using artificial intelligence (AI) to make childbirth safer. It is the first partnership of its kind, which aims to give health systems a chance to use cutting-edge technology to keep an eye on and interact with obstetrics patients at home during labor and after the baby is born. Hence, this coordinated solution for women's health can be used by all healthcare systems in the country.
It is the first collaboration to combine an inpatient labor and delivery solution with a post-discharge monitoring tool for the same patients. As a result, Memora and PeriGen customers' reports improved results significantly.
"Health systems offering robust maternal and fetal monitoring that supports new families during labor and throughout their transition home can gain tremendous lifetime loyalty from these investments," said Manav Sevak, Co-Founder and CEO of Memora Health.
He further added, "We're excited to partner with PeriGen to offer this innovative solution that can help health systems continue to use their digital assets as a key strategic lever to remain competitive in a challenging market." (Source: PR Newswire)
Perigen, a company owned by Halma, makes innovative perinatal software solutions that use advanced statistical analysis tools to make care during childbirth more efficient and consistent. The company comprises skilled OB doctors and IT experts. The PeriWatch® platform provides consistent analysis and efficient display of complex data to help people recognize and talk about problems that might happen during labor. With PeriWatch®, doctors and nurses can spend more time directly caring for patients and less time doing manual math and data work.
About Memora Health
Memora Health helps healthcare organizations digitize and automate care programs, making complex care delivery easier for patients and staff. It creates computerized programs that help guide patients through care episodes. Its strong knowledge of clinical workflows and patient experience allows the creation of coherent digital programs that guide patients through care episodes and automate easy EHR follow-up chores for care teams. The company's digital care programs reduce notifications to care teams by 40%, have an average patient NPS of over 70, and improve engagement and clinical results for many groups.
Surfacide, LLC | February 20, 2023
Surfacide®, the leading company in UV-C disinfection technology, recently announced that it is expanding the use of its Helios® low-level UV-C Disinfection System to all ten hospitals in the MedStar Health system across the Mid-Atlantic region. With a renewed emphasis on operating room disinfection, the expansion enables MedStar Health to update some of its existing Surfacide® technology and deploy multiple new devices, making the Helios System more accessible to patients, staff, and visitors.
Since 2016, Surfacide® has collaborated strategically with MedStar Health to implement UV-C disinfection to reduce the environmental variable in infection prevention protocols. In addition, it is an integral part of CompassOne Healthcare's ‘5 Pillars of Safety in Healthcare’ philosophy.
The Surfacide® Helios® system is the sole patented, low-level UV-C disinfection option that simultaneously employs three light-emitting 'robots' to reduce bacteria and viruses on contaminated surfaces significantly. It delivers UV-C energy to more exposed areas than individual devices, increasing power, dosage, and efficacy in a single cycle. The system is conveniently portable and configurable within various high-impact hospital areas, including patient rooms, ORs, patient bathrooms, burn units, labor & delivery, outpatient/ambulatory surgery, isolation wards, etc.
Founder and CEO of Surfacide®, Gunner Lyslo, shared, "With the expansion and renewed focus on a robust UV-C disinfection program, MedStar Health continues to demonstrate leadership and commitment to their patients, staff and community." He added, "We are thankful to work with such a tremendous partner and are confident that these strategies will positively impact patient and staff satisfaction."
(Source – PR Newswire)
Surfacide®, established in 2010 and headquartered in Waukesha (Wisconsin), is a prominent UV technology and infection solutions company that produces scientifically proven, hospital-grade UV devices. The company's award-winning Helios® System is the sole patented, triple emitter 'robotic' UV light solution that effectively reduces bioburden and pathogens. As a trusted partner in infection prevention, its products have been deployed in over 600 leading hospitals, dental offices, fire stations, nursing homes, prisons, commercial office spaces, police stations, hotels, and public venues worldwide.